These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 28951916)

  • 1. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
    Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
    Liu B; Monro S; Jabed MA; Cameron CG; Colón KL; Xu W; Kilina S; McFarland SA; Sun W
    Photochem Photobiol Sci; 2019 Oct; 18(10):2381-2396. PubMed ID: 31432864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
    Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
    Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
    Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
    Qin WW; Pan ZY; Cai DH; Li Y; He L
    Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes.
    Liu B; Monro S; Lystrom L; Cameron CG; Colón K; Yin H; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2018 Aug; 57(16):9859-9872. PubMed ID: 30091916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
    Li Y; Wang KN; He L; Ji LN; Mao ZW
    J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy.
    Yi S; Lu Z; Zhang J; Wang J; Xie Z; Hou L
    ACS Appl Mater Interfaces; 2019 May; 11(17):15276-15289. PubMed ID: 30968687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothiazole-decorated iridium-based nanophotosensitizers for photodynamic therapy of cancer cells.
    Wang X; Song K; Deng Y; Liu J; Peng Q; Lao X; Xu J; Wang D; Shi T; Li Y; Deng D; Miao Y
    Dalton Trans; 2022 Mar; 51(9):3666-3675. PubMed ID: 35165680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
    Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
    Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
    Negi M; Dixit T; Venkatesh V
    Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Design of Phosphorescent Iridium(III) Complexes for Selective Glutathione Sensing and Amplified Photodynamic Therapy.
    Huang T; Yu Q; Liu S; Zhang KY; Huang W; Zhao Q
    Chembiochem; 2019 Feb; 20(4):576-586. PubMed ID: 30267457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of pH-responsive cyclometalated iridium(III) complex and its application in the selective killing of cancerous cells.
    Yang P; Zhang S; Wang K; Qi H
    Dalton Trans; 2021 Nov; 50(46):17338-17345. PubMed ID: 34788356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity and mechanism studies of photoactivated iridium(III) complexes toward lung cancer A549 cells.
    Zhou L; Li J; Chen J; Yao X; Zeng X; Liu Y; Wang Y; Wang X
    Dalton Trans; 2024 Sep; 53(36):15176-15189. PubMed ID: 39221457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
    Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G
    Dalton Trans; 2024 Jul; 53(27):11393-11409. PubMed ID: 38899369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.